Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Astellas Files Personalized Tarceva In First-line Lung Cancer With FDA

Nov 20 2012

• By Emily Hayes

Related Content

Tarceva Could Lock Down Market For First-Line Non-Small Cell Lung Cancer With EGFR Mutation

Jan 28 2011

NSCLC Market Snapshot: Promising Biomarkers, Testing Challenges

May 30 2011

<em>Alimta</em> Lung Cancer Label Expanded To Include Longer Use

Oct 17 2012

Related Companies

Pfizer Inc.

Eli Lilly and Company

Boehringer Ingelheim GmbH

Additional Topics

Regulation Approvals

More from Approvals

More from Product Reviews

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window